Results 261 to 270 of about 1,239,019 (334)

Does mass drug administration for the integrated treatment of neglected tropical diseases really work?: assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda [PDF]

, 2011
Melissa Parker, Tim Allen
openalex  

Analysis of the Electrochemical Stability of Sulfide Solid Electrolyte Dry Films for Improved Dry‐Processed Solid‐State Batteries

Advanced Functional Materials, EarlyView.
An adapted processing for solvent‐free argyrodite solid electrolyte films based on insights into degradation mechanisms of the widely used binder polytetrafluoroethylene is presented. By adapting the dry film processing, long‐term cycling in Si||NMC pouch cells is demonstrated over more than 1000 cycles with a capacity retention of more than 80%, and ...
Maria Rosner, Sahin Cangaz, Felix Hippauf, Susanne Dörfler, Burak Aktekin, Thomas Meyer, Anja Henss, Thomas Abendroth, Holger Althues, Jürgen Janek, Stefan Kaskel   +10 more
wiley   +1 more source

Trends of Coverage of Mass Drug Administration, Population at Risk and Reported Cases of Schistosomiasis and Soil-Transmitted Helminths, Uganda, 2013-2023. [PDF]

BMC Infect Dis
Namara BG, Kwesiga B, Migisha R, Bulage L, Tinkitina B, Ario AR, Mubangizi A.   +6 more
europepmc   +1 more source

Epidemiology of Lymphatic Filariasis Antigen and Microfilaria in Samoa, 2019: 7–9 Months Post Triple-Drug Mass Drug Administration [PDF]

Helen J. Mayfield, Harriet Lawford, Benn Sartorius, Patricia M. Graves, Sarah Sheridan, Thérèse Kearns, Shannon M. Hedtke, Katherine Gass, Take Naseri, Robert Thomsen, Colleen L. Lau   +10 more
openalex   +1 more source

4D Mapping of ZIF Biocomposites for High Protein Loading and Tunable Release Profiles

Advanced Functional Materials, EarlyView.
Systematic four‐dimensional mapping of zeolitic imidazolate framework biocomposites reveals how precursor ratios, total concentration, and washing define crystalline phase, protein loading, and release kinetics. This comprehensive study identifies conditions yielding record loading (∼85%) and precise phase–property correlations.
Michael R. Hafner, Francesco Carraro, Behnaz Abbasgholi‐NA, Simone Dal Zilio, Max Schmallegger, Helmar Wiltsche, Lingcong Ge, Michael R. Reithofer, Efwita Astria, Laura Villanova, Heinz Amenitsch, Christian Doonan, Paolo Falcaro   +12 more
wiley   +1 more source

Fixed-dose ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis. [PDF]

PLoS Negl Trop Dis
Echazu A, Bonanno D, Fleitas PE, Jacobson J, Matamoros G, Mwandawiro C, Enbiale W, de Jesus Á, Brooks A, Krolewiecki AJ.   +9 more
europepmc   +1 more source

Time to change implementation units for mass drug administration against schistosomiasis in Uganda: Evidence from Communities levels data validation and its implication in planning

Moses Adriko, Benjamin Tinkitina, Moses Arinaitwe, Edridah M. Tukahebwa, Alfred Mubangizi, Jorge Cano, Honorat Zouré, Pauline N. Mwinzi, Boniface Kinvi, Amadou Garba, Sammy M. Njenga, Humphrey D. Mazigo   +11 more
openalex   +1 more source

Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals

Advanced Functional Materials, EarlyView.
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee, Sojin Kim, Myeongeun Lee, Kyoungsuk Jin, Jimin Park   +4 more
wiley   +1 more source

Evolutionary dynamics in the genome of ocular <i>Chlamydia trachomatis</i> strains from Northern Tanzania following mass drug administration. [PDF]

Microb Genom
Ghasemian E, Ramadhani A, Harte A, Mafuru E, Derrick T, Mtuy T, Massae P, Malissa A, Breuer J, Pickering H, Bailey RL, Mabey D, Burton MJ, Holland MJ.   +13 more
europepmc   +1 more source

Generating Cell Surface Nucleated Hydrogels with an Artificial Membrane‐Binding Transglutaminase

Advanced Functional Materials, EarlyView.
Cell‐based therapies require advanced strategies to enhance cell delivery and bioactivity. Cell membrane engineering offers an avenue to impart new functions to delivered cells to boost their viability and function. Here, an artificial membrane‐binding transglutaminase is generated and biophysically characterized.
Rosalia Cuahtecontzi Delint, Tao Li, Kapil D. Patel, Will H. Zhang, Ben M. Carter, Graham J. Day, Adam W. Perriman   +6 more
wiley   +1 more source